Tudriqev
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tudriqev. Get the full timeline:
Most recent: FDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma